Hints and tips:
Related Special Reports
Related Pages
...“I’d be surprised if there are UK fintech IPOs this year,” he said....
...Companies whose R&D claims have been rejected unexpectedly have been forced to change their business plans....
...“I’ve always said I’d love to be president, but you’d have to anoint me, folks,” Dimon said, to laughter from the crowd....
...and studios,” the company said in a joint statement with Canal+....
...He explains how he solved a problem in the third act of a kidnap drama for director Martin Scorsese (“who I’d turned down for Raging Bull”)....
...One: it doesn’t look like much but you’d miss it if it went. Two: it does a vital thing (decreasingly well, but it still does it)....
...But inside the company, D’Amaro is seen as a more natural communicator than Chapek, who some dismissively labelled as “a parks guy”....
...Should companies be punished for handing money back to shareholders? The Department of Justice seems to think so....
...UK-listed stocks, all of which are growing faster than international brand name blue-chip companies listed on the London market....
...Eventually, she’d like to add objects, such as glassware and ceramics....
...this year and 1.8mn b/d in 2025....
...“You’d have to hope that it doesn’t get disintermediated,” says Slowinski....
...When it comes to higher-end homes across the Côte d’Azur, prices experienced zero growth in the year to June 2023, according to Savills’ Prime Residential Index....
...Solar power companies and farmers team up in “quite a grassroots kind of way”, said ASGA president Nick Armentrout....
...at which loss-making companies are taxed within the merged scheme from 25 per cent to 19 per cent and lower the threshold for the additional support for R&D intensive lossmaking firms....
...But analysts at Jefferies said that worries about the company’s “R&D productivity will take time to lift”, pointing to a lack of significant trial results expected in 2024 and growth tailing off for the...
...The company spent €6.7bn on R&D last year. It plans to spend an additional €700mn next year. That is not eye-popping. Sanofi’s R&D spend last year was 15.6 per cent of revenues....
...AstraZeneca has invested heavily in R&D under Soriot’s tenure and has launched a string of blockbuster products including top-selling cancer drugs Tagrisso and Imfinzi, which brought in $1.6bn and $1.1bn...
...The company produced an average of 10.7mn b/d of crude oil and other liquids last year, down from 11.5mn b/d in 2022....
...“I used to forget the tiniest everyday things: I’d put eggs on to boil, I’d forget. Papers were stacked four feet high on my desk,” said Davis, 74....
...Nemer said committing to funding levels of $10bn-$15bn for R&D would be justified to tackle other pathogens....
...“We employ a consultancy to do our R&D claims for us because we haven’t got the time to fight the claims,” he said....
...The big one, of course, is interest rates, when they start to come down . . . we’d expect to see a more exuberant return to shopping.”...
...The Centers for Medicare & Medicaid Services said last month that Medicare Part D drug benefit plans will cover weight loss medicines when they are approved to treat a separate medical problem, such as heart...
We’d like to speak to couples who have considered signing a prenuptial agreement or deed of trust
International Edition